UK markets closed

Oncimmune Holdings Plc (ONC.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
23.00-0.50 (-2.13%)
At close: 03:24PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 17.42M
Enterprise value 19.52M
Trailing P/E N/A
Forward P/E 27.32
PEG ratio (5-yr expected) N/A
Price/sales (ttm)14.80
Price/book (mrq)26.52
Enterprise value/revenue 16.94
Enterprise value/EBITDA -4.40

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 3-41.98%
S&P500 52-week change 321.08%
52-week high 345.00
52-week low 313.00
50-day moving average 321.60
200-day moving average 321.81

Share statistics

Avg vol (3-month) 374.36k
Avg vol (10-day) 393.16k
Shares outstanding 574.14M
Implied shares outstanding 674.14M
Float 850.79M
% held by insiders 128.80%
% held by institutions 135.49%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Aug 2023
Most-recent quarter (mrq)31 Aug 2023

Profitability

Profit margin 356.25%
Operating margin (ttm)-340.62%

Management effectiveness

Return on assets (ttm)-26.38%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)1.15M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -2.94M
Net income avi to common (ttm)-6.15M
Diluted EPS (ttm)-0.08
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.21M
Total cash per share (mrq)0.04
Total debt (mrq)5.3M
Total debt/equity (mrq)806.85%
Current ratio (mrq)3.91
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-6.79M
Levered free cash flow (ttm)-4.41M